Nomenclature for factors of the HLA system, update June 2017.

Hum Immunol

Anthony Nolan Research Institute, Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom. Electronic address:

Published: September 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2017.07.003DOI Listing

Publication Analysis

Top Keywords

nomenclature factors
4
factors hla
4
hla system
4
system update
4
update june
4
june 2017
4
nomenclature
1
hla
1
system
1
update
1

Similar Publications

Background: Discussion surrounding the nomenclature of the "nonfluent/agrammatic" spectrum of progressive speech-language disorders has largely focused on the clinical-pathological and neuroimaging correlations, with some attention paid to the prognostication afforded by differentiating clinical phenotypes. Progressive apraxia of speech (AOS), with or without agrammatic aphasia, is generally associated with an underlying tauopathy; however, patients have offered a unique perspective on the importance of distinguishing between difficulties with speech and language that extends beyond pathological specificity. This study aimed to provide insight into the experience of patients with primary progressive AOS (PPAOS), with particular attention to their diagnostic journey.

View Article and Find Full Text PDF

Background: Best practice recommendations suggest a person close to a patient with mild cognitive impairment (MCI) or dementia be involved in their care. This person is often referred to as a "caregiver," though the term "care partner" has increasingly been used in research and care instead of "caregiver." Unlike "caregiver," "care partner" suggests a collaborative relationship between the patient and their support person, in which the patient actively participates rather than passively receives help.

View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study.

Diabetes Obes Metab

January 2025

Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, Key Laboratory of Prevention and Control of Major Diseases in the Population, Ministry of Education, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China.

Background: Fatty liver disease may be associated with increased risks of intrahepatic and extrahepatic cancers. Our objective was to investigate associations between new subcategories of steatotic liver disease (SLD) recently proposed by nomenclature consensus group and cancer risk.

Methods: A total of 283 238 participants from the UK Biobank were included.

View Article and Find Full Text PDF

Per- and poly-fluoroalkyl substances (PFAS) have emerged as a silent menace, infiltrating groundwater systems worldwide. Many countries, preoccupied with tackling legacy pollutants, have inadvertently neglected the emerging threat of PFAS. This review provides an exhaustive analysis beyond the current state of knowledge and sustainable pathways vis-a-vis addressing PFAS in groundwater systems globally.

View Article and Find Full Text PDF

Background: A new nomenclature of metabolic associated steatotic liver disease (MASLD) was proposed in 2023, thus expanding the diagnostic name of "MASLD combined with other etiologies".

Aim: To investigate the clinical profiles of patients with concurrent MASLD and chronic hepatitis B virus (HBV) infection.

Methods: This study included participants from the Taiwan Bio-bank.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!